Lupin secures USFDA approval for Loteprednol Etabonate Ophthalmic Gel Ruchika Sharma1 July 2025 4:38 PM ISTThe product is a corticosteroid indicated for the treatment of postoperative inflammation and pain following ocular surgery.
Haleon appoints Paritosh Gupta as India Head: Expert Sales Operations Ruchika Sharma1 July 2025 4:23 PM ISTNew Delhi: Haleon has appointed Paritosh Gupta as India Head: Expert Sales Operations.Paritosh Gupta shared the news of his new role via LinkedIn,...
Lupin carves out consumer healthcare business Ruchika Sharma1 July 2025 4:05 PM ISTMumbai: Global pharma major Lupin Limited, has announced the strategic carve-out of its consumer healthcare business, LupinLife Consumer...
USFDA approves Takeda Gammagard liquid ERC for primary immunodeficiency Ruchika Sharma1 July 2025 3:32 PM ISTJapan: Takeda has received approval from the U.S. Food and Drug Administration (FDA) for GAMMAGARD LIQUID ERC [immune globulin infusion (human)]...
HPV9 vaccine: Biological E to get exclusive right to commercialize REC603 in India Ruchika Sharma1 July 2025 2:30 PM ISTBiological E will begin large-scale manufacturing of the HPV9 vaccine once the Technology transfer is completed.
Aurobindo Pharma arm restarts production at Kakinada Penicillin-G plant after fire incident Ruchika Sharma1 July 2025 12:44 PM ISTHyderabad: Aurobindo Pharma has announced the recommencement of the production at Penicillin-G manufacturing facility of Lyfius Pharma Private...
Alembic Pharma bags USFDA nod for cancer injection Doxorubicin Hydrochloride Liposome Ruchika Sharma1 July 2025 11:38 AM ISTVadodara: Pharmaceutical firm, Alembic Pharmaceuticals Limited, has announced that the company has received final approval from the US...
Sanofi Riliprubart receives orphan drug designation in Japan for chronic inflammatory demyelinating polyneuropathy Ruchika Sharma1 July 2025 10:30 AM ISTParis: Sanofi has received orphan drug designation from the Ministry of Health, Labour and Welfare (MHLW) in Japan for riliprubart, a...
Hetero Labs' Acarbose-Sitagliptin-Metformin FDC Rejected by CDSCO Panel Over GI Risk Dr. Divya Colin30 Jun 2025 5:45 PM ISTNew Delhi: In a setback to Hetero Labs Limited, the Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organisation...
Biocon Biologics Expands Insulin Access in Malaysia Kajal Rajput30 Jun 2025 2:57 PM ISTBiocon Biologics Ltd. (BBL) on Monday announced that its Malaysian subsidiary, Biocon Sdn. Bhd., has surpassed the supply of 100 million cartridges of...
US FDA eliminates risk evaluation, mitigation strategies for CAR-T cancer therapies Jyoti Kumari30 Jun 2025 2:54 PM ISTBengaluru: The U.S. Food and Drug Administration said on Friday had eliminated risk evaluation and mitigation strategies (REMS), a safety program to...
CDSCO Clears Abbott's phase IV Trial Of Dydrogesterone MR Tablet Parthika Patel30 Jun 2025 2:53 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Reproductive division of the Central Drugs Standard Control Organization (CDSCO) has approved...
